Oracle Investment Management »

Ark Etf Tr gen rev mltsct shares owned by Oracle Investment Management

Quarter-by-quarter ownership of Ark Etf Tr gen rev mltsct (ARKG) shares owned by Oracle Investment Management from 13F filings

Historical chart of Oracle Investment Management investment in Ark Etf Tr gen rev mltsct

Tip: Access up to 7 years of quarterly data

All positions including Ark Etf Tr gen rev mltsct held by Oracle Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ark Etf Tr gen rev mltsct by Oracle Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $565k 20k 28.97
2021-12-31 $1.1M 350k 3.07

More positions owned by Oracle Investment Management

Genedx Holdings Corp Com Cl A (WGS)
Ardelyx (ARDX)
Biohaven (BHVN)
Teladoc Health Call Call Option
Novavax Note 5.000%12/1 Call Option (Principal)
Ardelyx Call Call Option
Quidel Corp (QDEL)
Forian Ord (FORA)
Personalis Ord (PSNL)
Biohaven Call Call Option
Teladoc (TDOC)
Taysha Gene Therapies Com Shs (TSHA)
Cava Group Ord (CAVA)
Edgewise Therapeutics (EWTX)
Day One Biopharmaceuticals I (DAWN)

View all positions for Oracle Investment Management

Top funds holding Ark Etf Tr gen rev mltsct

Jpmorgan Chase & Co
Bnp Paribas Arbitrage, Snc
Goldman Sachs Group
Citadel Advisors
UBS Group
Jane Street
Wells Fargo & Company
Susquehanna International
State of Wisconsin Investment Board
LPL Financial
Walleye Trading
Balyasny Asset Management
Cubist Systematic Strategies
Wolverine Trading
Kingsview Wealth Management

View all funds holding Ark Etf Tr gen rev mltsct